News
The deal will see Apple and MP Materials launch a recycling facility for processing recycled rare earth elements. Once ...
AstraZeneca on Wednesday said that its experimental drug anselamimab did not meet the main goal of a late-stage study for the treatment of AL amyloidosis, a rare condition that causes a buildup of ...
AZN hits all endpoints in phase III study for baxdrostat, a first-in-class treatment targeting hard-to-manage hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results